ATE411740T1 - Plastisches kaubares tierarzneipräparat mit hoher palatabilität - Google Patents

Plastisches kaubares tierarzneipräparat mit hoher palatabilität

Info

Publication number
ATE411740T1
ATE411740T1 AT04763629T AT04763629T ATE411740T1 AT E411740 T1 ATE411740 T1 AT E411740T1 AT 04763629 T AT04763629 T AT 04763629T AT 04763629 T AT04763629 T AT 04763629T AT E411740 T1 ATE411740 T1 AT E411740T1
Authority
AT
Austria
Prior art keywords
plastic
chewable veterinary
high palatability
veterinary product
product
Prior art date
Application number
AT04763629T
Other languages
English (en)
Inventor
Ute Isele
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34130042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE411740(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE411740T1 publication Critical patent/ATE411740T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
AT04763629T 2003-07-30 2004-07-29 Plastisches kaubares tierarzneipräparat mit hoher palatabilität ATE411740T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03017252 2003-07-30

Publications (1)

Publication Number Publication Date
ATE411740T1 true ATE411740T1 (de) 2008-11-15

Family

ID=34130042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04763629T ATE411740T1 (de) 2003-07-30 2004-07-29 Plastisches kaubares tierarzneipräparat mit hoher palatabilität

Country Status (22)

Country Link
US (3) US8628794B2 (de)
EP (1) EP1675474B9 (de)
JP (2) JP4925186B2 (de)
KR (1) KR101217429B1 (de)
CN (1) CN100488376C (de)
AR (1) AR045142A1 (de)
AT (1) ATE411740T1 (de)
AU (1) AU2004262492C1 (de)
BR (1) BRPI0413079B1 (de)
CA (1) CA2531150C (de)
CO (1) CO5650207A2 (de)
DE (1) DE602004017340D1 (de)
DK (1) DK1675474T4 (de)
ES (1) ES2313050T5 (de)
MX (1) MXPA06001080A (de)
NZ (1) NZ544890A (de)
PL (1) PL1675474T5 (de)
PT (1) PT1675474E (de)
RU (1) RU2356534C2 (de)
SI (1) SI1675474T1 (de)
TW (1) TWI366442B (de)
WO (1) WO2005013714A1 (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
DK1830883T3 (da) 2004-12-29 2013-11-25 Hills Pet Nutrition Inc Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr
EP1906912B1 (de) 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Verfahren zur verlängerung des lebens von tieren
NZ542100A (en) * 2005-08-30 2009-09-25 Vital Food Processors Ltd Animal medicament containing partially hydrolysed protein treated with plant derived proteolytic enzymes
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
CA2630990A1 (en) * 2005-12-12 2007-06-21 Hill's Pet Nutrition, Inc. Method for deriving a wellness related index for a food composition
BRPI0506279B1 (pt) * 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
AU2007100477B4 (en) * 2007-06-05 2007-07-05 Jurox Pty Ltd Parasiticide Composition
KR101769728B1 (ko) 2007-06-27 2017-08-18 이 아이 듀폰 디 네모아 앤드 캄파니 동물 해충 방제 방법
AU2014259503C1 (en) * 2007-06-27 2019-06-13 E. I. Du Pont De Nemours And Company Animal pest control method
CN101194672B (zh) * 2007-12-24 2012-09-05 新疆维吾尔自治区畜牧科学院兽医研究所 动物自动吞食剂
RU2367435C1 (ru) * 2008-03-26 2009-09-20 Александр Анатольевич Смирнов Состав для лечения гельминтозов домашних животных
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
RU2422142C2 (ru) * 2009-03-23 2011-06-27 Государственное научное учреждение (ГНУ) Всероссийский научно-исследовательский институт гельминтологии им. К.И. Скрябина (ВИГИС) Антигельминтное средство для лечения кабанов
TW201041507A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity and methods for preparing same
TW201041510A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
TW201041509A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
EP2453759B1 (de) * 2009-07-14 2015-10-21 Hill's Pet Nutrition, Inc. Haustierfuttermittel enthaltend einer verzögerten freisetzung form von liponsäure, deren verwendung und herstellungsverfahren
US8697174B2 (en) 2010-01-27 2014-04-15 Ainsworth Pet Nutrition Treats and methods for producing same
CN102933082A (zh) * 2010-04-22 2013-02-13 杰内塞斯实验室股份有限公司 用于防治白蛉和其它吸血昆虫的组合物和方法
WO2012001083A2 (en) * 2010-06-29 2012-01-05 Ceva Sante Animale Sa Novel eprinomectin injectable compositions
AU2011315555B2 (en) 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
WO2013037650A1 (fr) 2011-09-15 2013-03-21 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CN102503649B (zh) * 2011-12-02 2013-10-09 中国科学院沈阳应用生态研究所 一种侧耳素发酵液生产植物营养剂及其方法
EP3216448B8 (de) * 2012-02-06 2019-06-05 Boehringer Ingelheim Animal Health USA Inc. Parasitizide orale tiermedizinische zusammensetzungen mit systemisch wirkenden wirkstoffen, verfahren und verwendungen davon
WO2013130433A1 (en) * 2012-02-27 2013-09-06 Cappelli Barbara Composition for oral delivery of veterinary drugs and supplements to animals
RU2489026C1 (ru) * 2012-03-05 2013-08-10 Государственное научное учреждение (ГНУ) Всероссийский научно-исследовательский институт гельминтологии им. К.И. Скрябина (ВИГИС) Способ обезвреживания личинок трихинелл методом замораживания в тушках некоторых пушных зверей
WO2013150055A1 (en) 2012-04-04 2013-10-10 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
JP2013251935A (ja) * 2012-05-30 2013-12-12 Denso Corp アクチュエータ
US9173941B1 (en) * 2012-08-02 2015-11-03 Jeff Shear Sustained release bittering composition
WO2014053555A1 (en) 2012-10-04 2014-04-10 Novartis Ag Veterinary drug system
US9532946B2 (en) * 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
HK1216856A1 (zh) * 2012-12-19 2016-12-09 Bayer Animal Health Gmbh 具有改善的接受性和良好贮存稳定性的片剂
CN105451771B (zh) 2013-03-15 2020-05-19 阿根塔创新有限公司 可咀嚼配制物
RU2667748C1 (ru) * 2013-11-25 2018-09-24 Нестек Са Жевательная пищевая композиция с разбухшей текстурой
CA2985801C (en) 2015-05-16 2021-10-26 Big Heart Pet, Inc. Palatable expanded food products and methods of manufacture thereof
LT3298027T (lt) 2015-05-20 2021-08-10 Boehringer Ingelheim Animal Health USA Inc. Antihelmintiniai depsipeptido junginiai
US9808010B2 (en) 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
CN108601374A (zh) * 2015-09-15 2018-09-28 斯派克初姆布兰斯有限公司 动物咀嚼物制品及其制备方法
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
CA3015935C (en) * 2016-03-02 2019-09-03 Specialites Pet Food Palatable cat kibbles containing specific fat fractions
CN109475493A (zh) * 2016-05-12 2019-03-15 拜耳动物保健有限责任公司 制备用于对动物给药的成型体的方法
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019011502A2 (pt) * 2016-12-09 2019-11-05 Bayer Animal Health Gmbh preparação farmacêutica e método para sua fabricação
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
CN108926540A (zh) * 2017-05-25 2018-12-04 北京欧博方医药科技有限公司 一种用于制造药物递送的软咀嚼剂型的方法
CN110996920A (zh) 2017-07-26 2020-04-10 太杰先软嚼有限责任公司 用于兽医应用的无淀粉软咀嚼物
CA3072123A1 (en) 2017-08-17 2019-02-21 Ceva Sante Animale Oral compositions and the preparation methods thereof
KR102165805B1 (ko) * 2017-12-22 2020-10-14 주식회사 고려비엔피 기호성이 증진된 개과 동물용 경구 투여 제제
CN108185128A (zh) * 2018-03-10 2018-06-22 王艺霖 一种凝胶状狗粮的制备方法
CN110627805B (zh) * 2018-06-21 2022-05-20 浙江海正药业股份有限公司 十六元大环内酯类化合物及其制备方法与应用
AU2019301510B2 (en) 2018-07-09 2024-06-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
CN109260158A (zh) * 2018-09-28 2019-01-25 青岛康地恩动物药业有限公司 一种高水溶性高稳定性的地美硝唑预混剂
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
US12115162B2 (en) 2019-02-20 2024-10-15 Zoetis Services Llc Palatable formulations
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022000982A2 (pt) * 2019-07-22 2022-03-08 Intervet Int Bv Forma de dosagem veterinária mastigável macia
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
US20210068425A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions
EP3878436A1 (de) * 2020-03-09 2021-09-15 Bayer Animal Health GmbH Weicher kaubarer formkörper zur verabreichung an tiere
EP4135681B1 (de) * 2020-04-17 2025-06-25 Nabriva Therapeutics GMBH Antivirale verwendung von pleuromutilinen
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물
CN112006981B (zh) * 2020-07-30 2023-01-10 瑞普（天津）生物药业有限公司 一种长效复方驱虫药物液体制剂及其制备方法与应用
US20220047506A1 (en) 2020-08-12 2022-02-17 Villya LLC Praziquantel Formulations
CN116744917A (zh) 2020-09-04 2023-09-12 礼蓝美国公司 适口调配物
EP4507694A1 (de) 2022-04-15 2025-02-19 KRKA, d.d., Novo mesto Weiche kaubare veterinärmedizinische darreichungsform
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
WO2024059803A1 (en) * 2022-09-15 2024-03-21 In The Bowl Animal Health, Inc. Feed and methods for controlling intestinal tract parasitic worm infections in mammals
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics
WO2025029582A2 (en) * 2023-08-01 2025-02-06 Rubicon Scientific, Llc Maintaining diethylcarbamazine in an extruded daily ration animal feed product

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1313417A (en) * 1970-06-05 1973-04-11 United Nations Childrens Fund Process and apparatus for making human foods and animal feeds
US3843783A (en) * 1971-11-08 1974-10-22 Velsicol Chemical Corp Rodenticidal compositions and processes employing gelatinized amylaceous materials
GB1465055A (en) * 1973-04-11 1977-02-23 Mars Ltd Animal food
SE421991B (sv) * 1975-02-24 1982-02-15 Univ Kansas State Kokt, reagerat foder for idisslare och sett att framstella fodret
US4284652A (en) * 1977-01-24 1981-08-18 The Quaker Oats Company Matrix, product therewith, and process
DE2831936A1 (de) * 1978-07-20 1980-02-07 Basf Ag Thienylmethyl-phosphorsaeureester
DE2841668A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
IT8022968V0 (it) * 1980-10-01 1980-10-01 Norda Spa Autobraccio per alimentazione e scarico di macchine operatrici in genere.
US4393085A (en) * 1981-08-13 1983-07-12 General Foods Corporation Enzyme digestion for a dog food of improved palatability
JPS59108785A (ja) * 1982-11-25 1984-06-23 Sankyo Co Ltd ミルベマイシン類の５−オキシム誘導体
GB8505980D0 (en) * 1985-03-08 1985-04-11 Mars G B Ltd Structured food products
CH669201A5 (de) * 1986-05-05 1989-02-28 Warner Lambert Co Bei raumtemperaturen feste und freifliessende basiszusammensetzung fuer das druckformen.
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
JPH06100602A (ja) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd 経口固形製剤およびその製造方法
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
DE69523912T2 (de) * 1994-05-20 2002-06-27 Janssen Pharmaceutica N.V., Beerse Flubendazole-kautabletten für haustiere
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
PT810823E (pt) * 1995-02-24 2001-09-28 Novartis Ag Composicao para controlo de parasitas
GB9508443D0 (en) * 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
IT1282733B1 (it) * 1996-05-20 1998-03-31 Flarer S A Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
US6558730B1 (en) * 1997-07-01 2003-05-06 The Procter & Gamble Co. Potato-based fabricated snacks made from continuously sheeted doughs and methods for controlling the texture and organoleptical properties thereof
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
EP1900283A3 (de) 1998-03-23 2010-02-10 General Mills, Inc. Verkapselung von Komponenten in essbaren Produkten
EP1065944A1 (de) * 1998-04-02 2001-01-10 The Procter & Gamble Company Teigzusammensetzung zur herstellung von halbfertigprodukten und daraus hergestellte mehlhaltige snack-produkte
US6379725B1 (en) * 1998-05-05 2002-04-30 Natural Polymer International Corporation Protein-based chewable pet toy
DE29815956U1 (de) 1998-09-07 1998-11-19 Arnold, Gerhard, 65187 Wiesbaden Medikamententräger zur Verabreichung bei Tieren
US6387381B2 (en) * 1998-09-24 2002-05-14 Ez-Med Company Semi-moist oral delivery system
ES2255490T3 (es) * 1999-03-31 2006-07-01 Janssen Pharmaceutica N.V. Almidon pregelatinizado en una formulacion de liberacion controlada.
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
ES2254400T3 (es) * 2000-04-27 2006-06-16 Sankyo Lifetech Company Limited Derivados de la milbemicina 13-sustituidos, su preparacion y su uso contra insectos y otras pestes.
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1247456A3 (de) * 2001-02-28 2003-12-10 Pfizer Products Inc. Wohlschmeckende pharmazeutische Zusammensetzung für Haustiere
US6866862B2 (en) * 2001-10-05 2005-03-15 Rubicon Scientific Animal feeds including heartworm-prevention drugs
CA2462251C (en) * 2001-10-05 2011-09-20 Rubicon Scientific, Llc Animal feeds including actives and methods of using same
US7052712B2 (en) * 2001-10-05 2006-05-30 Rubicon Scientific Llc Animal feeds including actives and methods of preparing same
UA76810C2 (uk) * 2001-12-10 2006-09-15 Мерк Енд Ко., Інк. Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
CA2809147C (en) 2002-08-13 2016-02-16 Intervet International B.V. Compositions and process for delivering an additive
US20040037869A1 (en) † 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition

Also Published As

Publication number Publication date
AU2004262492C1 (en) 2010-04-15
MXPA06001080A (es) 2006-04-11
DK1675474T3 (da) 2009-02-16
AR045142A1 (es) 2005-10-19
BRPI0413079B1 (pt) 2015-11-17
KR20060052935A (ko) 2006-05-19
TWI366442B (en) 2012-06-21
EP1675474B1 (de) 2008-10-22
US8628794B2 (en) 2014-01-14
KR101217429B1 (ko) 2013-01-02
CN100488376C (zh) 2009-05-20
AU2004262492B2 (en) 2008-01-10
ES2313050T5 (es) 2017-11-28
US8541019B2 (en) 2013-09-24
DE602004017340D1 (de) 2008-12-04
PL1675474T5 (pl) 2017-12-29
ES2313050T3 (es) 2009-03-01
SI1675474T1 (sl) 2009-04-30
EP1675474B9 (de) 2018-12-05
PL1675474T3 (pl) 2009-04-30
CO5650207A2 (es) 2006-06-30
EP1675474B2 (de) 2016-12-07
US20140094418A1 (en) 2014-04-03
CA2531150C (en) 2012-07-10
BRPI0413079A (pt) 2006-10-03
WO2005013714A1 (en) 2005-02-17
JP4925186B2 (ja) 2012-04-25
CN1829448A (zh) 2006-09-06
AU2004262492A1 (en) 2005-02-17
NZ544890A (en) 2008-07-31
JP2007500004A (ja) 2007-01-11
DK1675474T4 (en) 2017-02-27
JP2011126882A (ja) 2011-06-30
US20060222684A1 (en) 2006-10-05
RU2356534C2 (ru) 2009-05-27
RU2006105785A (ru) 2007-09-10
US20120046296A1 (en) 2012-02-23
PT1675474E (pt) 2008-11-03
TW200526130A (en) 2005-08-16
CA2531150A1 (en) 2005-02-17
EP1675474A1 (de) 2006-07-05

Similar Documents

Publication Publication Date Title
ATE411740T1 (de) Plastisches kaubares tierarzneipräparat mit hoher palatabilität
EP1610613A4 (de) Topische anthelmintika-formulierungen für den veterinärbereich
DE60315349D1 (de) Reifen mit reifenetikett
DE602004026621D1 (de) Rfid-etikett mit verbesserter lesbarkeit
DE50307161D1 (de) Hochviskose Formmassen mit nanoskaligen Füllstoffen
DE60209895D1 (de) Reifenbauteile mit verbessertem elastizitätsmodul
DE50300545D1 (de) Stossstange mit Halterungen
DK1431199T3 (da) Plasttönde
DE602004005901D1 (de) Spritzgießverfahren
DK1463551T3 (da) Veterinærmedicinsk spröjte
DE602004014280D1 (de) Flammgeschützte thermoplastische harzzusammensetzung
DE602004019930D1 (de) Flammgeschützte thermoplastische harzzusammensetzung
ITMI20010897A0 (it) Rulli di guida per calibratori di estrusione di film plastici
DE502004001130D1 (de) Metallisiertes, elektrolumineszentes Kunststoff-Formteil
DE60329337D1 (de) Flammgeschützte thermoplastische harzzusammensetzung
EP1545862A4 (de) Thermoplastformverfahren
AT500755B8 (de) Drahtförderung mit konstantem moment
DE502004002166D1 (de) Thermoplastische Polyamid-Formmassen
DE50312292D1 (de) Einspritzmodul
DE50307085D1 (de) Spreizdübel aus kunststoff
ATA1182002A (de) Schneckenextruder
DE50311598D1 (de) Kunststoff-Spritzguss-Formteil
DE112004000012D2 (de) Kunststoffprodukt mit integriertem Low-Cost-Chip
DE502004001380D1 (de) Vorderschaft aus Kunststoff
DE50211655D1 (de) Aus kunststoff bestehendes werkzeug

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1675474

Country of ref document: EP